APA ציטוט

Krendyukov, A., Kneisel, N., Zhu, J., Merz, C., Richards, D., Gieffers, C., . . . Mitchell, T. (2020). The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model. Elsevier.

Chicago Style (17th ed.) Citation

Krendyukov, A., N. Kneisel, J. Zhu, C. Merz, D. Richards, C. Gieffers, B. Van Den Eynde, and T. Mitchell. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.

ציטוט MLA

Krendyukov, A., et al. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.